Title |
A role for the neurexin–neuroligin complex in Alzheimer's disease
|
---|---|
Published in |
Neurobiology of Aging, November 2013
|
DOI | 10.1016/j.neurobiolaging.2013.09.032 |
Pubmed ID | |
Authors |
Ikhlas A. Sindi, Rudolph K. Tannenberg, Peter R. Dodd |
Abstract |
Synaptic damage is a critical hallmark of Alzheimer's disease, and the best correlate with cognitive impairment ante mortem. Synapses, the loci of communication between neurons, are characterized by signature protein combinations arrayed at tightly apposed pre- and post-synaptic sites. The most widely studied trans-synaptic junctional complexes, which direct synaptogenesis and foster the maintenance and stability of the mature terminal, are conjunctions of presynaptic neurexins and postsynaptic neuroligins. Fluctuations in the levels of neuroligins and neurexins can sway the balance between excitatory and inhibitory neurotransmission in the brain, and could lead to damage of synapses and dendrites. This review summarizes current understanding of the roles of neurexins and neuroligins proteolytic processing in synaptic plasticity in the human brain, and outlines their possible roles in β-amyloid metabolism and function, which are central pathogenic events in Alzheimer's disease progression. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 1% |
Israel | 1 | <1% |
Germany | 1 | <1% |
Mexico | 1 | <1% |
United Kingdom | 1 | <1% |
Unknown | 142 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 31 | 21% |
Researcher | 27 | 18% |
Student > Bachelor | 26 | 18% |
Student > Master | 13 | 9% |
Student > Postgraduate | 8 | 5% |
Other | 20 | 14% |
Unknown | 23 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 47 | 32% |
Biochemistry, Genetics and Molecular Biology | 21 | 14% |
Neuroscience | 20 | 14% |
Medicine and Dentistry | 18 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
Other | 12 | 8% |
Unknown | 25 | 17% |